SEP-363856 (SEP-856)是具有口服活性的、中枢神经系统活性的抗精神病活性化合物,具有治疗精神分裂症的潜能。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
SEP-363856 (SEP-856), an orally active and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects. SEP-363856 (SEP-856) has the potential for the treatment of schizophrenia[1].
[1]. Dedic N, et al. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action. J Pharmacol Exp Ther. 2019 Oct;371(1):1-14.
Quinupristin-Dalfopristin Complex (mesylate)
¥2560.00 ¥3200.00
Tankyrase Inhibitors (TNKS) 49
¥1320.00 ¥1650.00
没有评价数据